IPM clocks Rs 7389 crores in March 2015
Eight therapies have outgrown the IPM growth and all therapies have double digit growths
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Pharma EM issues not as straightforward: Experts
Conference attended by regulatory affairs experts and pharma companies
Rebooting Jan Aushadhi
As Prime Minister Modi completes a year in office this May, there will no doubt be many lists of this government’s achievements…
US FDA public meeting on June 15 on reauthorisation of GDUFA
Looking for suggestions especially on performance assessment of GDUFA and which aspects should be retained, changed, or…
Biocon top line grows 15 per cent in Q4 FY15
Research services subsidiary Syngene delivers 27 per cent growth
Pharmexcil organises series of initiatives during CPhI Japan
Brand India Pharma was strongly represented by Indian pharma companies at various platforms
Aditi Kare Panandikar receives the Ohio State University Award
She get the award for her outstanding contribution to the pharmaceutical industry
Aditi Kare Panandikar, Managing Director,…
CII launches online certification courses on IPR
Lecturers to be experienced legal luminaries, academicians and stalwarts with a say in shaping India’s IPR policy
Wockhardt recalls 12 drugs in US made at 2 India units
Wockhardt said this was a measure of preparedness and abundant precaution and there is no evidence of risk to patient safety from…
Carbopol Workshop – Oral Formulations
Lubrizol LifeSciences will organise Carbopol Workshop – Oral Formulations